Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters











Database
Publication year range
1.
mBio ; 11(5)2020 10 20.
Article in English | MEDLINE | ID: mdl-33082253

ABSTRACT

Mycobacterium kansasii is an environmental nontuberculous mycobacterium that causes opportunistic tuberculosis-like disease. It is one of the most closely related species to the Mycobacterium tuberculosis complex. Using M. kansasii as a proxy for the M. kansasii-M. tuberculosis common ancestor, we asked whether introducing the M. tuberculosis-specific gene pair Rv3377c-Rv3378c into M. kansasii affects the course of experimental infection. Expression of these genes resulted in the production of an adenosine-linked lipid species, known as 1-tuberculosinyladenosine (1-TbAd), but did not alter growth in vitro under standard conditions. Production of 1-TbAd enhanced growth of M. kansasii under acidic conditions through a bacterial cell-intrinsic mechanism independent of controlling pH in the bulk extracellular and intracellular spaces. Production of 1-TbAd led to greater burden of M. kansasii in the lungs of C57BL/6 mice during the first 24 h after infection, and ex vivo infections of alveolar macrophages recapitulated this phenotype within the same time frame. However, in long-term infections, production of 1-TbAd resulted in impaired bacterial survival in both C57BL/6 mice and Ccr2-/- mice. We have demonstrated that M. kansasii is a valid surrogate of M. tuberculosis to study virulence factors acquired by the latter organism, yet shown the challenge inherent to studying the complex evolution of mycobacterial pathogenicity with isolated gene complementation.IMPORTANCE This work sheds light on the role of the lipid 1-tuberculosinyladenosine in the evolution of an environmental ancestor to M. tuberculosis On a larger scale, it reinforces the importance of horizontal gene transfer in bacterial evolution and examines novel models and methods to provide a better understanding of the subtle effects of individual M. tuberculosis-specific virulence factors in infection settings that are relevant to the pathogen.


Subject(s)
Lipids/biosynthesis , Mycobacterium kansasii/genetics , Mycobacterium tuberculosis/genetics , Animals , Culture Media/chemistry , Evolution, Molecular , Female , Hydrogen-Ion Concentration , Lung/microbiology , Macrophages/microbiology , Male , Mice , Mice, Inbred C57BL , Mycobacterium kansasii/physiology , Mycobacterium tuberculosis/physiology , Tuberculosis/microbiology
2.
J Infect Dis ; 222(6): 1046-1050, 2020 08 17.
Article in English | MEDLINE | ID: mdl-32301995

ABSTRACT

Mycobacterium kansasii is a slow-growing nontuberculous mycobacteria responsible for coinfections particularly in patients with human immunodeficiency virus. To date, our knowledge of M. kansasii infection has been hampered owing to the lack of an effective animal model to study pathogenesis. In the current study, we showed that the zebrafish embryo is permissive to M. kansasii infection, resulting in chronic infection and formation of granulomas. On macrophage depletion, we identified M. kansasii forms extracellular cords, resulting in acute infection and rapid larval death. These findings highlight the feasibility of zebrafish for studying M. kansasii pathogenesis and for the first time identify extracellular cords in this species.


Subject(s)
Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium kansasii/physiology , Animals , Host-Pathogen Interactions/immunology , Larva , Mycobacterium Infections, Nontuberculous/immunology , Phagocytes/immunology , Phagocytes/metabolism , Phagocytes/microbiology , Phagocytosis/immunology , Zebrafish
4.
PLoS One ; 7(4): e36292, 2012.
Article in English | MEDLINE | ID: mdl-22558425

ABSTRACT

Mycobacterium kansasii has emerged as an important nontuberculous mycobacterium pathogen, whose incidence and prevalence have been increasing in the last decade. M. kansasii can cause pulmonary tuberculosis clinically and radiographically indistinguishable from that caused by Mycobacterium tuberculosis infection. Unlike the widely-studied M. tuberculosis, little is known about the innate immune response against M. kansasii infection. Although inflammasome activation plays an important role in host defense against bacterial infection, its role against atypical mycobacteria remains poorly understood. In this report, the role of inflammasome activity in THP-1 macrophages against M. kansasii infection was studied. Results indicated that viable, but not heat-killed, M. kansasii induced caspase-1-dependent IL-1ß secretion in macrophages. The underlying mechanism was found to be through activation of an inflammasome containing the NLR (Nod-like receptor) family member NLRP3 and the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). Further, potassium efflux, lysosomal acidification, ROS production and cathepsin B release played a role in M. kansasii-induced inflammasome activation. Finally, the secreted IL-1ß derived from caspase-1 activation was shown to restrict intracellular M. kansasii. These findings demonstrate a biological role for the NLRP3 inflammasome in host defense against M. kansasii.


Subject(s)
Carrier Proteins/metabolism , Inflammasomes/metabolism , Mycobacterium kansasii/physiology , CARD Signaling Adaptor Proteins , Caspase 1/metabolism , Cathepsin B/metabolism , Cell Line, Tumor , Cytoskeletal Proteins/metabolism , Enzyme Activation/immunology , Humans , Hydrogen-Ion Concentration , Immunity, Innate , Interleukin-1beta/metabolism , Intracellular Space/immunology , Intracellular Space/metabolism , Intracellular Space/microbiology , Lysosomes/metabolism , Macrophages/immunology , Macrophages/metabolism , Macrophages/microbiology , NLR Family, Pyrin Domain-Containing 3 Protein , Potassium/metabolism , Reactive Oxygen Species/metabolism
5.
Chem Pharm Bull (Tokyo) ; 59(2): 179-84, 2011.
Article in English | MEDLINE | ID: mdl-21297296

ABSTRACT

A set of 1160 minimum inhibitory concentration (MIC) values evaluating effect of substitution on the antimycobacterial activity of the previously published 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles has been analyzed by the methods of multidimensional analysis (exploratory analysis, 2D-nonlinear mapping (NLM), principal component analysis (PCA), factor analysis (FA), multiple linear regression (MLR)). The antimycobacterial activity of 2-(subst. benzyl)sulfanyl derivatives of benzimidazole (BIM), 5-methylbenzimidazole (5-Me-BIM), benzoxazole (BOZ), and benzothiazole (BTZ) increased in the order of BTZ

Subject(s)
Anti-Bacterial Agents/chemistry , Benzimidazoles/chemistry , Benzothiazoles/chemistry , Benzoxazoles/chemistry , Anti-Bacterial Agents/pharmacology , Benzimidazoles/pharmacology , Benzothiazoles/pharmacology , Benzoxazoles/pharmacology , Microbial Sensitivity Tests/methods , Mycobacterium avium/drug effects , Mycobacterium avium/physiology , Mycobacterium kansasii/drug effects , Mycobacterium kansasii/physiology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/physiology , Quantitative Structure-Activity Relationship
6.
Chin Med J (Engl) ; 123(2): 184-7, 2010 Jan 20.
Article in English | MEDLINE | ID: mdl-20137367

ABSTRACT

BACKGROUND: An increasing incidence of disease caused by nontuberculous mycobacteria (NTM) is being reported. The purpose of this study was to determine the isolation rates of NTM from various clinical specimens, and their antimicrobial susceptibility patterns, over a 4-year period in Shanghai. METHODS: All NTM isolated between 2005 and 2008 at Shanghai Pulmonary Hospital, a key laboratory of mycobacteria tuberculosis in Shanghai, China, were identified with conventional biochemical tests and 16S rRNA gene sequencing. Antimicrobial susceptibility for all NTM was determined using the BACTEC MGIT 960 system. RESULTS: A total of 21,221 specimens were cultured, of which 4868 (22.94%) grew acid fast bacilli (AFB), and 248 (5.09%) of the AFB were NTM. The prevalence rate of NTM was determined as 4.26%, 4.70%, 4.96% and 6.38% among mycobacteria culture positive samples in years 2005, 2006, 2007 and 2008 respectively. These data indicated that the prevalence rate has continuously increased. Sixteen different species of NTM were identified, the most commonly encountered NTM in Shanghai were M. chelonae (26.7%), followed by M. fortuitum (15.4%), M. kansasii (14.2%), M. avium-intracellulare complex (13.1%) and M. terrae (6.9%). The rare species identified were M. marinum, M. gastri, M. triviale, M. ulcerans, M. smegmatis, M. phlci, M. gordonae, M. szulgai, M. simiae, M. scrofulaceum and M. xenopi. The five most commonly identified NTM species showed high drug resistance to general anti-tuberculosis drugs, particularly, M. chelonae and M. fortuitum appear to be multi-drug resistance. CONCLUSIONS: The prevalence of NTM in Shanghai showed a tendency to increase over the course of the study. The five most commonly isolated NTM species showed high drug resistance to first line anti-tuberculosis drugs.


Subject(s)
Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Mycobacterium/drug effects , Mycobacterium/physiology , Antitubercular Agents/pharmacology , China/epidemiology , Drug Resistance, Bacterial , Mycobacterium chelonae/drug effects , Mycobacterium chelonae/physiology , Mycobacterium fortuitum/drug effects , Mycobacterium fortuitum/physiology , Mycobacterium kansasii/drug effects , Mycobacterium kansasii/physiology , Mycobacterium marinum/drug effects , Mycobacterium marinum/physiology , Mycobacterium xenopi/drug effects , Mycobacterium xenopi/physiology , Nontuberculous Mycobacteria/drug effects , Nontuberculous Mycobacteria/physiology , Prevalence
7.
J Antimicrob Chemother ; 47(4): 417-20, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11266413

ABSTRACT

Mycobacterium kansasii was administered intravenously to congenitally athymic (nude) mice. Beginning 1 week later, rifapentine, azithromycin, ethambutol or combined therapy was initiated orally. All three drugs were highly active individually. Although there was no evidence of antagonism, combined therapy was not more effective than either component used alone.


Subject(s)
Azithromycin/therapeutic use , Ethambutol/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium kansasii , Rifampin/analogs & derivatives , Rifampin/therapeutic use , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Azithromycin/administration & dosage , Drug Interactions , Drug Therapy, Combination , Ethambutol/administration & dosage , Mice , Mice, Inbred BALB C , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium kansasii/physiology , Rifampin/administration & dosage , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL